Literature DB >> 6285220

Impaired immunocompetence in patients with malignant gliomas: the possible role of Tg-lymphocyte subpopulations.

M A Gerosa, A Olivi, M L Rosenblum, G P Semenzato, A Pezzutto.   

Abstract

T-lymphocyte subpopulations (Tg or "suppressor cells" and Tm or "helper cells") in the peripheral blood of 16 patients with malignant intracranial gliomas were analyzed. The number of Tm-lymphocytes was very close to normal in both pre- and postoperative samples, whereas Tg-lymphocytes were significantly increased preoperatively (18.55 +/- 1.11 vs. 12.72 +/- 1.19 p less than 0.001) and were still slightly higher than normal after operation and radiation treatment. These preliminary findings suggest a possible role of T-suppressor lymphocytes in the impairment of cell-mediated immunocompetence that has been observed repeatedly in patients with malignant gliomas.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6285220     DOI: 10.1227/00006123-198205000-00004

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  5 in total

Review 1.  Microenvironmental clues for glioma immunotherapy.

Authors:  Michael Platten; Katharina Ochs; Dieter Lemke; Christiane Opitz; Wolfgang Wick
Journal:  Curr Neurol Neurosci Rep       Date:  2014-04       Impact factor: 5.081

2.  Lymphocyte subsets in patients with brain tumors.

Authors:  M Uegaki; S Kobayashi; S Kuramoto; M M Yokoyama
Journal:  J Neurooncol       Date:  1988       Impact factor: 4.130

3.  Particular features of cell-mediated immunity in patients with anaplastic gliomas. A comparison with kidney and bladder cancer patients.

Authors:  F Servadei; R Parente; M Bucci; E Beltrandi; F Tognetti; G Gaist
Journal:  J Neurooncol       Date:  1983       Impact factor: 4.130

4.  Immunological studies in patients with central nervous system tumors.

Authors:  L Palma; V Moschese; E Galli; C Barbieri; V R Lombardi; P Rossi
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

5.  Prostaglandin E2 as an immunomodulating factor released in vitro by human glioma cells.

Authors:  G M Lauro; N Di Lorenzo; M Grossi; A Maleci; B Guidetti
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.